The Group secured two gold awards and one silver
Top honors, for the third year in a row, were won by the BIOIATRIKI Group (Yiannoukas Chemistry – Alpha Euresis) at the Cyprus Healthcare Business Awards 2022. The Group received a gold award in the “Innovative Equipment” category for the Multi-Diagnostic Center it opened in 2022 in Nicosia, gold in the “Quality of Services” category for all of its services and silver in the “Innovative Diagnostic Center Unit” category for the Versatile Center.
The aim of the event was to highlight and reward the excellence of businesses and professionals in health area.
The Operations and Development Director of BIOIATRIKI Group in Cyprus, Mr. Anastasios Kalogiannis, receiving the 3 awards said: “It is a special honor and pleasure to be here today, for the 3rd consecutive year, in order to receive awards that reflect our effort and commitment on the triptych of Quality-Reliability-Innovation”.
Mr. Kalogiannis first of all thanked the citizens who trust the BIOIATRIKI Group centers for their exams every day, highlighting at the same time the collective effort of the Group's human resources and the his commitment to the values he advocates.
He also emphasized that the Group will continue to invest with the same determination and with the aim of continuous improvement of primary health care in Cyprus and concluded his speech with the words of the president of the BIOIATRIKI Group, Mr. Georgios Spanos “We are here for health everyone!”.
BIOIATRIKI Group has been active in Cyprus since 2017 having undertaken the creation, staffing and operation of the clinical laboratory of the German Oncology center, while at the same time it acquired the majority share package of Giannoukas Chemistry and the ALFA EURESIS Diagnostic Center. The highlight of the innovations he introduced is the creation of the first Multi-Diagnostic Center in Cyprus, where examinees have the possibility to simultaneously carry out radiodiagnostic and clinical laboratory examinations with leading medical equipment that includes artificial intelligence technology and full automation for the least possible strain on the examinees and the maximum reliability of diagnostic results. The Group maintains a total of 17 facilities throughout Cyprus, offering the possibility of performing more than 3,500 clinical examinations and all imaging tests.
< iframe width='300px' height='500px' src='https://www.adstorebluebird.cy/api/banner/ServeBanner?zoneId=2734' frameborder='0' scrolling='no'>
